ClinicalTrials.gg
RecruitingNCT06083558Updated Oct 16, 2023

Pain and Nausea After Gallbladder Surgery

An observational study in PONV, Postoperative Pain and Postoperative Complications, sponsored by Umeå University. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-16.

Sponsored by Umeå University · Observational

From the registry’s dates

  • Started Jan 2016; still recruiting 10 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
50,000
Ages
18 Years and older
Sex
All
01

Study summary

The study is primarily an exploratory study of quality registry data for a swedish national cohort of patients who have undergone gallbladder surgery or ERCP, with the aim of investigating the occurrence of pain and PONV (Postoperative Nausea and Vomiting) after gallbladder surgery. Furthermore, the investigators will explorer if there are factors related to the patient or the surgical procedure that are associated with a higher risk of PONV or pain.

Read the detailed description

The project is a registry study with linked data from the Swedish national registry for gallbladder surgery (Gallriks) and the Swedish Perioperative Register (SPOR).

In SPOR, multiple variables are recorded and the main categories include patient characteristics, process data (e.g., times, operating room, planning, cancellations), surgical data (diagnosis, procedure, anesthesia type, times, deviations), and postoperative data (e.g., pain, nausea, complications, times, postoperative care level). The main variables of interest in this project are postoperative nausea and vomiting (PONV) and pain. In SPOR, it is possible to register whether the patient experienced nausea or vomiting and to assess pain in the immediate postoperative period during the stay at the postoperative recovery unit (PACU). The mean time of stay at PACU after gallbladder surgery in Sweden is 3.5 hours.

Gallriks records data related to gallstone surgery, including preoperative factors (including patient's illness), surgical processes, and postoperative outcomes up to 6 months after surgery.

The investigators have estimated that it is possible to include at least 50% of all gallstone surgeries in Sweden, which corresponds to a range of 7,000-8,000 patients per year.

Both quality registers are housed at the Uppsala Clinical Research Center (UCR), which will perform the data linkage. The data extraction process will start with the surgical cases in Gallriks and match them with SPOR. The database delivered to the research group will contain only pseudonymized personal data, with personal identification numbers and names removed.

The objectives of the study are:

  • Describe the risk of early PONV (Postoperative Nausea and Vomiting) and pain during the PACU stay following gallstone surgery.
  • Identify factors associated with early PONV and pain.
  • Test the hypothesis that total intravenous anesthesia has a lower risk of PONV and pain at the PACU compared to inhalation-based anesthesia.
  • Test the hypothesis that the addition of a regional block reduces the risk of PONV and pain during the PACU stay.
  • Test the hypothesis that patients who experience PONV and/or pain in the postoperative ward have a higher risk of postoperative complications up to 6 months after surgery.

The primary outcome measures are:

  • Risk of PONV in the postoperative ward (number of surgical cases with nausea and/or vomiting) / [total number of surgical cases].
  • Median pain score (NRS) in the postoperative ward.
  • Risk of severe pain (NRS>=7) [number of surgical cases with NRS>=7] / [total number of surgical cases].
  • Percentage of patients with complications, unplanned hospitalizations, or reoperations after 30 days and 6 months.
  • Based on the data in SPOR and Gallriks, identify factors associated with the primary outcome measures. Variables hypothesized to be associated include gender, age, illness, preoperative pain, type of anesthesia, type of surgery, and length of hospital stay.
  • Specifically examine whether total intravenous anesthesia or regional blockade reduces the risk of PONV/pain and whether PONV/pain increases the risk of postoperative complications.

The data will be described using descriptive methods, and associations will be analyzed through univariate and multivariate analysis.

The study database is planned to include the procedures performed during the years 2016-2025. Databases will be delivered on a yearly basis. Analysis and reports/manuscripts from the study might include parts of the whole study period of 10 years.

02

Conditions studied

  • PONV
  • Postoperative Pain
  • Postoperative Complications
  • Gall Bladder Disease

Keywords

  • cholecystectomy
03

In context

Postoperative Nausea and Vomiting

638 studies on the registry are indexed under Postoperative Nausea and Vomiting; 110 are open to participants now.

This study's planned enrollment of 50,000 is above the median of 208 across 93 observational studies indexed under Postoperative Nausea and Vomiting.

Browse Postoperative Nausea and Vomiting studies →

Lead sponsor

Umeå University is the lead sponsor of 272 studies on the registry; 60 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patients that had undergone gallbladder surgery in Sweden.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primary gallstone surgery
  • Adult patients (>=18 years)
  • Procedure performed between 2016 and 2025
  • Surgical procedure registered in the national quality registry Gallriks.

Exclusion criteria

Exclusion Criteria:

  • If multiple surgeries on the same patient in the study database, subsequent procedures to the first procedure is excluded.
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
50,000 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Postoperative nausea and vomiting

    Incidence of PONV in the postoperative ward (number of surgical cases with nausea and/or vomiting) / \[total number of surgical cases\].

    Time frame: Through the stay at the PACU, an average of 3.5 hours

  2. Postoperative Pain

    Median pain score (NRS) in the postoperative ward. NRS = Numerical Rating Scale 0-10. 0 = No pain and 10 = Worst imaginable pain

    Time frame: Through the stay at the PACU, an average of 3.5 hours

  3. Severe postoperative pain

    Incidence of severe pain (NRS\>=7) \[number of surgical cases with NRS\>=7\] / \[total number of surgical cases\]. NRS = Numerical Rating Scale 0-10. 0 = No pain and 10 = Worst imaginable pain

    Time frame: Through the stay at the PACU, an average of 3.5 hours

  4. Complications after surgery

    Percentage of patients with complications, unplanned hospitalizations, or reoperations after 30 days and 6 months

    Time frame: up to 6 month

07

Study locations

1 of 1 sites recruiting
  • Umeå University, Dept of surgical and perioperative sciences
    Sundsvall, X 85357, Sweden
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 16, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06083558
Lead sponsor
Umeå University
Responsible party
Sponsor
First posted
Oct 16, 2023
Start date
Jan 1, 2016
Primary completion
Dec 31, 2027 (estimated)
Completion
Mar 2028 (estimated)
Last update
Oct 16, 2023

Study contacts

Jakob Wallden, MD PhD
Contact
jakob.wallden@umu.se
+46703644392
Tomi Myrberg, MD PhD
Contact
tomi.myrberg@umu.se
Jakob Wallden, MD PhD
principal investigator · Umeå University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion